ArticlePloS one2020

Altered expression of SIRPγ on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells.

Sushmita Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.